RU2004134447A - APPLICATION OF THE PRODUCT "MEXICOR" (2-Ethyl-6-methyl-3-hydroxypyridine succinate) for the treatment of nephritis and nephropathy - Google Patents

APPLICATION OF THE PRODUCT "MEXICOR" (2-Ethyl-6-methyl-3-hydroxypyridine succinate) for the treatment of nephritis and nephropathy Download PDF

Info

Publication number
RU2004134447A
RU2004134447A RU2004134447/15A RU2004134447A RU2004134447A RU 2004134447 A RU2004134447 A RU 2004134447A RU 2004134447/15 A RU2004134447/15 A RU 2004134447/15A RU 2004134447 A RU2004134447 A RU 2004134447A RU 2004134447 A RU2004134447 A RU 2004134447A
Authority
RU
Russia
Prior art keywords
mexicor
nephritis
nephropathy
ethyl
methyl
Prior art date
Application number
RU2004134447/15A
Other languages
Russian (ru)
Other versions
RU2290930C2 (en
Inventor
Павел Юрьевич Тюриков (RU)
Павел Юрьевич Тюриков
Original Assignee
Общество с ограниченной ответственностью "ЭКОФАРМИНВЕСТ" (RU)
Общество с ограниченной ответственностью "Экофарминвест"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ЭКОФАРМИНВЕСТ" (RU), Общество с ограниченной ответственностью "Экофарминвест" filed Critical Общество с ограниченной ответственностью "ЭКОФАРМИНВЕСТ" (RU)
Priority to RU2004134447/15A priority Critical patent/RU2290930C2/en
Publication of RU2004134447A publication Critical patent/RU2004134447A/en
Application granted granted Critical
Publication of RU2290930C2 publication Critical patent/RU2290930C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Применение препарата Мексикор (2-этил-6-метил-3-оксипиридина сукцината) впервые в качестве лекарственного препарата у больных нефритами и нефропатиями на фоне традиционной терапии, включающей реолитики, антикоагулянты и антиагреганты, ингибиторы АПФ и противовоспалительные средства.The use of Mexicor (2-ethyl-6-methyl-3-hydroxypyridine succinate) for the first time as a drug in patients with nephritis and nephropathy on the background of traditional therapy, including rheolytics, anticoagulants and antiplatelet agents, ACE inhibitors and anti-inflammatory drugs.
RU2004134447/15A 2004-11-26 2004-11-26 Application of 2-ethyl-6-methyl-3-oxypyridine succinate for treatment of nephritis and nephropathy RU2290930C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2004134447/15A RU2290930C2 (en) 2004-11-26 2004-11-26 Application of 2-ethyl-6-methyl-3-oxypyridine succinate for treatment of nephritis and nephropathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004134447/15A RU2290930C2 (en) 2004-11-26 2004-11-26 Application of 2-ethyl-6-methyl-3-oxypyridine succinate for treatment of nephritis and nephropathy

Publications (2)

Publication Number Publication Date
RU2004134447A true RU2004134447A (en) 2006-05-10
RU2290930C2 RU2290930C2 (en) 2007-01-10

Family

ID=36656621

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004134447/15A RU2290930C2 (en) 2004-11-26 2004-11-26 Application of 2-ethyl-6-methyl-3-oxypyridine succinate for treatment of nephritis and nephropathy

Country Status (1)

Country Link
RU (1) RU2290930C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020191502A1 (en) * 2019-03-27 2020-10-01 Algernon Pharmaceuticals Inc. Use of emoxypine and derivatives thereof for treating kidney disorders and inflammatory bowel disease

Also Published As

Publication number Publication date
RU2290930C2 (en) 2007-01-10

Similar Documents

Publication Publication Date Title
NO20053920D0 (en) Preparation and treatment of demyelination diseases and paralysis in the administration of remyelination agents.
EP1848418A4 (en) Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection
DE602004017194D1 (en) PYRIDYLPYRROL DERIVATIVES AS ACTIVE KINASE INHIBITORS
NO20053224D0 (en) Patient controlled drug administration device.
BRPI0416628A (en) use of organic compounds
ECSP055701A (en) NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME
MX2009004203A (en) Acetaminophen / ibuprofen combinations.
NO20065878L (en) Therapeutic compounds
TW200609004A (en) Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihistamines
EA200701159A1 (en) COMBINED MEDICINE INCLUDING TELMISARTAN AND HYDROCHLORTHIAZIDE
DK1781277T3 (en) Combination composition comprising Ibuprofen and Paracetamol
CY1112184T1 (en) PYRIDOXAMINE FOR USE IN TREATMENT OF DIABETIC Nephropathy in Type II Diabetes
NO20055136D0 (en) Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin disorders
IL177047A0 (en) Oxazole derivatives, preparation and therapeutic use thereof
DK1773796T3 (en) Oxopiperidine derivatives, their preparation and their therapeutic use
WO2006074265A3 (en) Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
CY1108932T1 (en) Compounds 4- (heterocyclyl) -benzenesulfoximine for the therapeutic treatment of inflammatory diseases
RU2007122391A (en) S-MIRTAZAPINE FOR TIDAL TREATMENT
CL2004000877A1 (en) PHARMACEUTICAL COMBINATION THAT INCLUDES 8A) MELATONIN AND MELATONINE AGONISTS, AND NICOTINE AND NICOTINE RECEIVING AGONISTS; PHARMACEUTICAL KIT, AND; USE IN THE TREATMENT OF INSOMNIUM, COGNITIVE DIFFICULTIES AND MEMORY DIFFICULTIES; FARMACEU KIT
RU2004134447A (en) APPLICATION OF THE PRODUCT "MEXICOR" (2-Ethyl-6-methyl-3-hydroxypyridine succinate) for the treatment of nephritis and nephropathy
CL2004001272A1 (en) COMPOUNDS DERIVED FROM 3- (4-METOXI-7-MORFOLIN-4-IL-BENZOTIAZOL-2-IL) -1,1-DISUSTITUDE-UREA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF THE COMPOUND IN THE TREATMENT OF RELATED DISEASES CO
DE60327249D1 (en) ANTHRANILIC ACID AMIDE AND ITS PHARMACEUTICAL USE
IS8356A (en) Medications, methods and dose control for the treatment and prevention of acute coronary heart disease
WO2006117624A3 (en) Kynurenic acid and salts thereof for the prevention and treatment of shock
PL371269A1 (en) 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20191127